护士主导的个体化随访对比医生主导的常规随访在早期乳腺癌术后的效果(MyHealth):一项III期随机对照试验
MyHealth是一项III期随机对照试验,将近期完成原发治疗的I-II期乳腺癌患者随机分为护士主导的个体化随访(自我管理课程、症状报告与就医导航)或医生主导的常规门诊随访。2年时干预组乳腺癌特异性生活质量显著且具临床意义地优于对照组,复发恐惧、焦虑、抑郁更少,医生咨询更少而护士接触更多,诊断影像模式不变,效果稳定至3年随访。
要点
- 护士主导随访组2年生活质量均值75.69,高于对照组71.26,平均差异5.05(95%CI 3.30至6.79;P<.001)。
- 干预组复发恐惧、焦虑、抑郁显著更少,医生咨询更少、护士接触更多,诊断影像模式不变。
- 所有结局的效果稳定维持至3年随访。
核心结论
- MyHealth研究提示护士主导的个体化随访可作为早期乳腺癌术后随访的新策略,因其显著改善了生活质量。
研究设计与样本
- MyHealth是一项III期随机对照试验(ClinicalTrials.gov标识符NCT02949167)。
- 近期完成I-II期乳腺癌原发治疗的患者按可变区组随机分配并依据年龄和人表皮生长因子受体2状态分层,分为干预随访或对照随访。
- 护士主导干预包括三至五次个体自我管理课程、定期症状报告和就医导航;对照随访为医生定期门诊随访。
- 主要结局为随机分配后2年时由癌症治疗功能评估-乳腺癌的试验结局指数-生理/功能/乳腺汇总评分测量的乳腺癌特异性生活质量。
- 在1,101例合格患者中,875例被邀请,503例随机分配至对照组(n=252)或干预组(n=251)。
主要发现
- 2年时干预组生活质量均值75.69(标准差12.27),对照组71.26(标准差14.08),平均差异5.05(95%CI 3.30至6.79;P<.001)。
- 干预组报告的复发恐惧、焦虑和抑郁显著更少。
- 干预组医生咨询更少但护士接触更多,诊断影像模式不变。
- 所有结局的效果稳定维持至3年随访。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Follow-up after breast cancer with regular visits has failed to detect recurrences, be cost-effective, and address patient needs. METHODS: MyHealth is a phase III randomized controlled trial (ClinicalTrials.gov identifier: NCT02949167). Patients, who recently completed primary treatment for stage I-II breast cancer, were randomly assigned in variable block sizes and stratified by age and human epidermal growth factor receptor 2 status to intervention or control follow-up. The nurse-led intervention comprised three to five individual self-management sessions, regular reporting of symptoms, and navigation to health care services. The control follow-up comprised regular outpatient visits with the physician. The primary outcome was breast cancer-specific quality of life (QoL) measured by the Trial Outcome Index-Physical/Functional/Breast summary score of the Functional Assessment of Cancer Therapy-Breast 2 years after random assignment. Secondary outcomes were fear of recurrence, anxiety, depression, and health care utilization. Analyses were intention-to-treat and P values were two-sided with 95% confidence level set at 0.005 because of multiple comparisons. RESULTS: Among 1,101 eligible patients, 875 were invited and 503 were randomly assigned to control (n = 252) or intervention (n = 251) follow-up. At 2 years, patients in the intervention group reported a significantly and clinically relevant higher QoL (mean, 75.69 [standard deviation [SD], 12.27]) than patients in the control group (71.26 [SD, 14.08]), with a mean difference of 5.05 (95% CI, 3.30 to 6.79; P < .001). The intervention group reported significantly less fear of recurrence, anxiety, and depression; they had fewer physician consultations but more nurse contacts and an unchanged diagnostic imaging pattern. The effect on all outcomes was stable through a 3-year follow-up. CONCLUSION: The MyHealth study suggested a new strategy for follow-up after early breast cancer as it provided significant improvements in QoL.
引用
- Saltbæk L, Bidstrup PE, Karlsen RV, et al. Nurse-Led Individualized Follow-Up Versus Regular Physician-Led Visits After Early Breast Cancer (MyHealth): A Phase III Randomized, Controlled Trial. J Clin Oncol. 2024. PMID: 38498781. doi:10.1200/JCO.23.01447
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。